Show simple item record

dc.contributor.authorLebovitz, Yeonwoo
dc.contributor.authorRingel-Scaia, Veronica M.
dc.contributor.authorAllen, Iriving C.
dc.contributor.authorThesus, Michelle H.
dc.date.accessioned2018-11-19T18:31:58Z
dc.date.available2018-11-19T18:31:58Z
dc.date.issued2018-09-03
dc.identifier.urihttp://hdl.handle.net/10919/85878
dc.description.abstractFrom immunology to neuroscience, interactions between the microbiome and host are increasingly appreciated as potent drivers of health and disease. Epidemiological studies previously identified compelling correlations between perinatalmicrobiome insults and neurobehavioral outcomes, the mechanistic details of which are just beginning to take shape thanks to germ-free and antibiotics-based animal models. This review summarizes parallel developments from clinical and preclinical research that suggest neuroactive roles for gut bacteria and their metabolites. We also examine the nascent field of microbiome-microglia crosstalk research, which includes pharmacological and genetic strategies to inform functional capabilities of microglia in response to microbial programming. Finally, we address an emerging hypothesis behind neurodevelopmental disorders, which implicates microbiome dysbiosis in the atypical programming of neuroimmune cells, namely microglia.
dc.description.sponsorshipThe authors acknowledge funding fromthe National Institutes of Health DK105975 (IA), NS096281 (MT), and NS081623 (MT); Virginia-Maryland College of Veterinary Medicine & Via College of Osteopathic Medicine Center for One Health Research Grant (MT, IA); Virginia-Maryland College of Veterinary Medicine Internal Research Competition (IA). Yeonwoo Lebovitz is supported through Virginia Tech Interdisciplinary Graduate Education Program in Regenerative Medicine and the Dannon Yogurt, Probiotics and the Gut Microbiome Fellowship Grant. VR-S is supported through the American Association of Immunologists Careers in Immunology Fellowship Program. Publication costs were supported by Virginia Tech Open Access Subvention Fund. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIHor any other funding agency.We apologize to any colleagues whose work was not included due to length constraints.
dc.format.mimetypeapplication/pdfen_US
dc.language.isoen_US
dc.publisherFrontiers
dc.rightsCreative Commons Attribution 4.0 International (CC BY 4.0)*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectautism
dc.subjectbacterial metabolites
dc.subjectgut bacteria
dc.subjectlactobacillus
dc.subjectmicrobiota
dc.subjectneurodevelopment
dc.subjectneuroimmune
dc.titleEmerging Developments in Microbiome and Microglia Research: Implications for Neurodevelopmental Disordersen_US
dc.typeArticle - Refereeden_US
dc.title.serialFrontiers in Immunology
dc.identifier.doihttps://doi.org/ 10.3389/fimmu.2018.01993
dc.identifier.volume9
dc.type.dcmitypeTexten_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Creative Commons Attribution 4.0 International (CC BY 4.0)
License: Creative Commons Attribution 4.0 International (CC BY 4.0)